REFERENCES
- Locatelli F, Pisoni RL, Combe C, et al. Anaemia in hemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004; 19: 121–132
- Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004; 19: 1–47
- El Nahas M. The global challenge of chronic kidney disease. Kidney Int. 2005; 68: 2918–2929
- Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC. Hemoglobin targets: We were wrong, time to move on. Lancet. 2007; 369: 346–350
- Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004; 44: 94–111
- Braumann KM, Nonnast-Daniel B, Boning D, Bocker A, Frei U. Improved physical performance after treatment of renal anemia with recombinant human erythropoietin. Nephron. 1991; 58: 129–134
- Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: Focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006; 26: 68–79
- National Kidney Foundation II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis. 2006; 47: 16–85
- Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target hemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis. Lancet. 2007; 369: 381–388
- Valderrabano F, Horl WH, Jacobs C, et al. European best practice guidelines 1–4: Evaluating anaemia and initiating treatment. Nephrol Dial Transplant. 2000; 15: 8–14
- National Kidney Foundation Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: 1–249
- Pollock CML. The CARI guidelines. Biochemical and haematological targets guidelines. Hemoglobin. Nephrology (Carlton). 2006; 10: S108–S115
- Horl WH, Vanrenterghem Y, Canaud B, et al. Optimal treatment of renal anaemia (OPTA): Improving the efficacy and efficiency of renal aneamia therapy in hemodialysis patients receiving intravenous epoetin. Nephrol Dial Transplant. 2005; 20: 25–32
- Collins AJ, Roberts TL, St Peter WL, et al. United States Renal Data System assessment of the impact of the National Kidney Foundation—Dialysis Outcomes Quality Initiative guidelines. Am J Kidney Dis. 2002; 39: 784–795
- Jacobs C, Frei D, Perkins AC. Results of the European Survey on Anaemia Management 2003 (ESAM 2003). Current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last five years. Nephrol Dial Transplant. 2005; 20: 3–24
- Valderrabano F, Horl WH, Macdougall IC, et al. PRE-dialysis survey on anaemia management. Nephrol Dial Transplant. 2003; 18: 89–100
- Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: A systematic review. JAMA. 1998; 280: 1339–1346
- Grimshaw J, Freemantle N, Wallace S, et al. Developing and implementing clinical practice guidelines. Qual Health Care. 1995; 4: 55–64
- Friedman C, Wyatt J. Evaluation Methods in Medical Informatics. Springer, New York 1997
- EBPG Working Party. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant. 1999; 14: 1–50